Navigation Links
Pharmaceutical Litigation Teleconference Feb. 23
Date:2/3/2009

PHILADELPHIA, Feb. 3 /PRNewswire/ -- HB Litigation Conferences LLC, formerly Mealey's Conferences, is hosting a CLE-accredited teleconference entitled "Hot Topics in Pharmaceutical Litigation 2009" on Feb. 23 at 2 p.m. Eastern Time.

The program will focus on the following products: Byetta, Trasvaginal Surgical Mesh Patch, Digitek, Yasmin birth control pills and NuvaRing.

Topics include: Product backgrounds; product liability overviews; updates on case filings; the alleged injuries; medical evidence; and multi-district litigation.

Attorney Vance Andrus of Andrus-Boudreux PLC of Lafayette, Louisiana and Denver is moderating the 100-minute call. On the panel are J. Paul Sizemore of Girardi Keese in Los Angeles, Donald A. Migliori of Motley Rice LLC in Providence, R.I., Fred Thompson III of Motley Rice in Mount Pleasant, S.C., Lowell W. Finson of Phillips & Associates in Phoenix and Thomas A. Clark of Andrus-Boudreaux in Lafayette, La.

Liability issues surrounding Byetta, Trasvaginal Surgical Mesh Patch, Digitek, Yasmin birth control pills and NuvaRing are the most urgent for plaintiff and defense attorneys practicing in the drug and medical device litigation arena.

For more information contact HB Litigation Conferences at (484) 324-2755 or email the company at info@litigationconferences.com. This product liability teleconference, as are all HB teleconferences, will be taped for people who cannot attend.

HB Litigation Conferences LLC, formerly Mealey's Conferences, is a leading provider of legal education conferences, teleconferences and multimedia content covering insurance, reinsurance, toxic torts, products liability, construction defects, and complex commercial and financial litiga
'/>"/>

SOURCE HB Litigation Conferences LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ISTA Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference
2. Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference
3. MAP Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Unit Dose Budesonide Collaboration with AstraZeneca
4. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
5. West Pharmaceutical Services To Present at the 2009 UBS Global Healthcare Services Conference
6. Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel(R) Litigation Settlement
7. Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities
8. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
9. Major Shareholders Criticize Enzon Pharmaceuticals Management Team in Open Letter
10. BioCryst Pharmaceuticals to Announce Fourth Quarter and Year End 2008 Financial Results on February 6, 2009
11. Tianyin Pharmaceutical Co., Inc. Begins Initial Share Buyback under its Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that can ... for those same twenty-plus years, the team at Doctors on ... the best possible doctor. With the combined breadth of ...
(Date:1/22/2015)... January 22, 2015 Yesterday, Senator ... (D-Concord) and Kristin Olsen (R-Modesto) were honored by ... in advancing biotechnology, biomedical science, medical device and ... each received the “2014 Life Sciences Champion” award ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... has released a new blog post presenting a list of vehicles ... , Some types of vehicles cannot be covered under an ... post to see if their vehicle qualifies for auto insurance coverage. ... the cars that cannot be covered by a plan. Clients have ...
(Date:12/26/2014)... The US represents the largest market for CRC across ... estimates that sales of branded therapies were $2.23 billion. The ... incidence of the disease, high drug treatment rate, and higher ... sales of CRC therapies over the forecast period will be ...
Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... have engineered a way to deliver health-promoting nutrients using ... breakthrough could lead to low fat or non-fat foods ... and could be used to enrich foods with other ... ,The team, led by Dr. Yoav D. Livney of ...
... future of cancer detection and treatment may be in gold ... be seen by the naked eye.// The potential of gold ... in a stable, nontoxic form that can be injected into ... found that a plant extract can be used to overcome ...
... leading pharmaceutical companies, issued a press release that stated ... cancer. ,A Phase III clinical trial ... (mitoxantrone) plus prednisone. The study included a little over ... disease after hormonal therapy., ,The results of the ...
... Delhi: The incidence of malaria, one of the most common ... cases in 2005 to 1.2 million cases in 2006, the ... the social sectors, the Economic Survey said malaria deaths came ... this period. ,According to it, in some parts ...
... pounds should add daily walks and limit TV time and ... // ,“The childbearing years are a time of particular ... Oken, M.D. “Modifiable behaviors in that early postpartum period — ... a woman’s risk of retaining weight.” ,Oken and ...
... could have better success rates following surgery, thanks to ... ,The study was published in the February, 2007 issue ... journal of the American Academy of Otolaryngology-Head and Neck ... Otolaryngology, the study measured success rates of patching eardrum ...
Cached Medicine News:Health News:Natural Milk Protein Could Lead to Super Nutritious Foods 2Health News:Common Ingredient in Big Macs and Sodas Can Stabilize Gold Nanoparticles for Medical Use 2Health News:Common Ingredient in Big Macs and Sodas Can Stabilize Gold Nanoparticles for Medical Use 3Health News:Incidence of Malaria Has Come Down, Says Economic Survey 2Health News:Simple Solutions to Postpartum Weight Retention 2Health News:Inner-ear Volume Study Leads to Higher Surgery Success Rates 2
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... discovery and development company, is delighted to announce that the ... awarded to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for ...
(Date:1/22/2015)... Jan. 22, 2015  BiOptix is pleased to announce the ... President of Chemistry and Biochemistry. Scott joins the company after ... and Amgen throughout the course of his nearly 20 ... "Scott is a nationally recognized thought leader in the ...
(Date:1/22/2015)... 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the ... therapies for cardiovascular disease and overall health is pleased to ... 2014 and its outlook for 2015 from the CEO, Mr. ... We would like to take this opportunity to share ...
Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) ... announce that it has completed the acquisition of ... of hard-to-find and specialty drugs.  In addition to ... markets Clotamin ® , a specialized over-the-counter multivitamin ...
... YORK, Feb. 29, 2012 Keryx Biopharmaceuticals, Inc. (NASDAQ: ... the acquisition, development and commercialization of medically important pharmaceutical ... and renal disease (the "Company"), today announced its results ... 2011. At December 31, 2011, the Company ...
Cached Medicine Technology:Sunpeaks Ventures Completes Acquisition of Healthcare Distribution Specialists LLC 2Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 Financial Results 3Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 Financial Results 4Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 Financial Results 5
The Micro-Temp® II safely and consistently delivers a therapeutic level of localized heat using a pump, connecting hose and localized temperature therapy pad....
Flat Wire Stone Basket...
Stainless Steel Paired Helical Basket...
4 hour identification of over 70 medically important, oxidase-negative, gram-negative bacilli, including E. coli, based on enzyme technology....
Medicine Products: